日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus

对临床试验药物VV261作为对抗基孔肯雅病毒的有效抗病毒候选药物进行研究

Zhang, Yumin; Tang, Sheng; Chen, Lu; Song, Shufen; Cao, Junyuan; Tian, Guanghui; Xiao, Gengfu; Shen, Jingshan; Zhang, Leike

Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors

基于结构的超广谱3C样蛋白酶抑制剂的开发

Su, Haixia; Nie, Tianqing; Chen, Guofeng; Xiong, Muya; Zhang, Yumin; Wu, Guoqing; You, Mengyuan; Xie, Hang; He, Jian; Xiong, Yanchao; Hu, Hangchen; Zhao, Wenfeng; Li, Minjun; Xiao, Gengfu; Zhang, Leike; Xu, Yechun

Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease

猴痘病毒I7L蛋白酶的动态帽介导底物进入和强效抑制剂设计

Su, Haixia; Wu, Guoqing; Xiong, Muya; Wang, Yuhang; Cao, Junyuan; You, Mengyuan; Xiang, Yingchun; Nie, Tianqing; Li, Minjun; Xiao, Gengfu; Zhang, Leike; Shao, Qiang; Xu, Yechun

Targeting viral suppressor of RNAi confers anti-coronaviral activity

靶向RNAi病毒抑制因子可赋予抗冠状病毒活性

Chen, Jiyao; Mu, JingFang; Zhou, Kangping; Zhang, Yuming; Zhang, Jieling; Shu, Ting; Shang, Weijuan; Ren, Yujie; Xu, Xi-Qiu; Zhang, Leike; Yuan, Shuai; Zhang, Dingyu; Cai, Kun; Qiu, Yang; Zhou, Xi

The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection

口服核苷类药物VV116是治疗尼帕病毒感染的一种很有前景的候选药物。

Zhang, Yumin; Yao, Yanfeng; Song, Shufen; Gao, Ge; Peng, Yun; Liu, Hang; Chen, Miaoyu; Zheng, Wei; Tian, Guanghui; Xie, Yuanchao; Shen, Jingshan; Xiao, Gengfu; Hu, Tianwen; Shan, Chao; Zhang, Leike

Discovery and mechanistic insights of dibenzoylmethane as a broad spectrum inhibitor of coronavirus.

二苯甲酰甲烷作为冠状病毒广谱抑制剂的发现和机制研究

Sun Yuan, Shu Xiaoyang, Chen Lu, Shang Weijuan, Zhang Yumin, Xiao Gengfu, Zhang Leike

Design, Synthesis, and Biological Evaluation of Peptidomimetic Tetrahydropyrrole Spirodihydroindolones as SARS-CoV-2 3CL Protease Inhibitors

肽模拟四氢吡咯螺二氢吲哚酮类化合物作为SARS-CoV-2 3CL蛋白酶抑制剂的设计、合成及生物学评价

Hu, Liuyan; Zhao, Zhi; Zhang, Shujing; Yang, Lei; Cui, Wenjie; Hu, Tianwen; Suo, Jin; Sun, Haiguo; Zhang, Qiumeng; Zhang, Leike; Zhu, Weiliang; Xu, Zhijian; Zhang, Yumin; Jiang, Xiangrui; Zhang, Yan; Shen, Jingshan

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection

口服的4'-氟尿苷前药可抑制SFTSV和LCMV感染

Jian, Xiaoqin; Hu, Tianwen; Xu, Huan; Wen, Yuxi; Zhang, Yumin; Xu, Mengwei; Jiang, Xiaming; Cao, Junyuan; Xiang, Li; Shen, Jingshan; Tian, Guanghui; Xiao, Gengfu; Zhang, Leike

Oral VV261 administration protects mice from lethal Crimean-Congo hemorrhagic fever virus challenge

口服VV261可保护小鼠免受致命的克里米亚-刚果出血热病毒攻击。

Wang, Xi; Xu, Huan; Li, Liushuai; Wu, Fan; Li, Jiang; Shen, Jingshan; Xiao, Gengfu; Zheng, Wei; Zhang, Leike; Hu, Zhihong; Wang, Manli

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

口服西诺替韦治疗轻度至中度新冠肺炎成人患者

Cao, Bin; Wang, Yeming; Lu, Hongzhou; Huang, Chaolin; Yang, Yumei; Shang, Lianhan; Chen, Zhu; Jiang, Rongmeng; Liu, Yihe; Lin, Ling; Peng, Ping; Wang, Fuxiang; Gong, Fengyun; Hu, Honglin; Cheng, Cong; Yao, Xiangyang; Ye, Xianwei; Zhou, Hourong; Shen, Yinzhong; Liu, Chenfan; Wang, Chunying; Yi, Zhennan; Hu, Bijie; Xu, Jiuyang; Gu, Xiaoying; Shen, Jingshan; Xu, Yechun; Zhang, Leike; Fan, Jia; Tang, Renhong; Wang, Chen